Clinical Trials Announcement
Important update from the ThrombUS+ Horizon Europe project: ethics approved and first patient enrolled! This advancement is a critical step […]
Project Overview
The ThrombUS+ project is focused on developing a novel wearable diagnostic device to aid in the early detection and diagnosis of deep vein thrombosis (DVT). The project integrates cutting-edge technologies, including ultrasound, artificial intelligence, light reflection rheography, plethysmography, serious games, and extended reality, to create a comprehensive and user-friendly monitoring system. ThrombUS+ aims to provide patients and healthcare professionals with real-time insights, enhancing DVT diagnosis and treatment.
The ThrombUS+ project is funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 101137227 (Horizon Innovation Action | HORIZON-HLTH-2023-TOOL-05-05) and is co-funded by the European Union.
42 months
Starting Date: 1 January 2024
Ending Date: 30 June 2027
18 partners from Greece, Lithuania, France, Germany, USA, Italy, Finland and Spain
9.5 M€ budget
co-funded by the Horizon Europe Programme
Wearable Continuous Point-of-Care Monitoring, Risk Estimation and Prevention for Deep Vein Thrombosis
News & Events
1 year of ThrombUS+
News and accomplishments from the first year of the ThrombUS+ Horizon Europe project. ThrombUS+ is a medical device that incorporates […]
Meet the Partner: TELEMED
Telemed is a pioneer in the field of medical imaging and ultrasound technology. Read about their involvement in the ThrombUS+ […]
Horizon Innovation Action | Agreement No. 101137227
HORIZON-HLTH-2023-TOOL-05-05
Co-funded by the European Union
S2E2 Certified